Drug shortages homepage

Welcome to Drug Shortages Canada, the website for mandatory reporting of drug shortages and discontinuations by market authorization holders. Anyone can search the database of shortage and discontinuation reports. More information can be found on the About & Resources Page.

Early reporting of shortages and discontinuations provides Health Canada, provincial/territorial governments, drug supply chain stakeholders, and health professionals details needed to help them monitor and manage supply. Shortages can be caused by many factors. Some last longer and are more complex than others. Because companies have to report every time they cannot fully meet demand, not all of the reports on this site are cause for concern at the patient level. Most are successfully managed before they impact patients.

The shortage database has a flag that indicates ones that are Tier 3 drug shortages, which are those that could potentially have the highest impact on Canada's drug supply and health care system. A Tier 3 designation is decided by the Tier Assignment Committee (TAC), composed of federal and provincial/territorial governments, healthcare professionals, and industry stakeholders.

Ensuring people can get the medicines they need is a top priority for Health Canada. Health Canada works closely with many partners to prevent shortages, mitigate their impacts, and help resolve them when they occur.

If you would like to know more about shortages like why they happen, how long they last, the actions being taken to reduce impacts on Canadians, and actions you can take if a drug you use is in shortage, please consult the information on Canada.ca.

Below are the newest shortage and discontinuation reports and updates to existing ones.

Drug pills

LEGEND

!!T3 denotes an actual Tier 3 shortage/discontinuation

!T3 denotes an anticipated Tier 3 shortage/discontinuation

Shortage Reports

Brand name Company Name Status Strength Update Date Updated View Report
RELPAX BGP PHARMA ULC Actual shortage 40MG Updated Report 2025-02-15 250228
FENTANYL INJECTION BP STERIMAX INC Resolved 250MCG Updated Report 2025-02-15 242920
IRBESARTAN SANIS HEALTH INC Actual shortage 300MG Updated Report 2025-02-15 243736
APO-RISPERIDONE APOTEX INC Actual shortage 4.0MG Updated Report 2025-02-14 246062
APO-RISPERIDONE APOTEX INC Resolved 1.0MG Updated Report 2025-02-14 240627
APO-METRONIDAZOLE TABLETS APOTEX INC Resolved 250MG Updated Report 2025-02-14 249080
APO-BRIVARACETAM APOTEX INC Resolved 75MG Updated Report 2025-02-14 248486
APO-OLANZAPINE ODT APOTEX INC Resolved 5MG Updated Report 2025-02-14 247901
APO-PANTOPRAZOLE APOTEX INC Resolved 40MG Updated Report 2025-02-14 244896
APO-ROSUVASTATIN APOTEX INC Resolved 40MG Updated Report 2025-02-14 243190

Discontinuation Reports

Brand name Company Name Status Strength Update Date Updated View Report
TROSEC SUNOVION PHARMACEUTICALS CANADA INC To be discontinued 20MG Updated Report 2025-02-10 250062
KIVEXA VIIV HEALTHCARE ULC To be discontinued 300MG 600MG Updated Report 2025-02-07 238375
CASODEX ASTRAZENECA CANADA INC Discontinued 50MG Updated Report 2025-02-07 231878
SKYRIZI ABBVIE CORPORATION Discontinued 75MG Updated Report 2025-02-06 248607
NUTROPIN AQ NUSPIN 5 HOFFMANN-LA ROCHE LIMITED Discontinued 5MG Updated Report 2025-02-01 232071
NUTROPIN AQ NUSPIN 10 HOFFMANN-LA ROCHE LIMITED Discontinued 10MG Updated Report 2025-02-01 232079
NUTROPIN AQ NUSPIN 20 HOFFMANN-LA ROCHE LIMITED Discontinued 20MG Updated Report 2025-02-01 232086
PAXIL TAB 10MG GLAXOSMITHKLINE INC To be discontinued 10MG Updated Report 2025-01-31 224405
NRA-FLECAINIDE NORA PHARMA INC Discontinued 100MG New Report 2025-01-29 249046
NRA-FLECAINIDE NORA PHARMA INC Discontinued 50MG New Report 2025-01-29 249043
PMSC-METFORMIN PHARMASCIENCE INC To be discontinued 850MG New Report 2025-01-28 248801
PMSC-METFORMIN PHARMASCIENCE INC To be discontinued 500MG New Report 2025-01-28 248798
APO-AMITRIPTYLINE APOTEX INC To be discontinued 50MG Updated Report 2025-01-27 247469
CARBOLITH BAUSCH HEALTH, CANADA INC. Discontinued 150MG Updated Report 2025-01-23 247417
ACULAR LS ABBVIE CORPORATION To be discontinued 0.4% New Report 2025-01-23 248365
TARO-ZOLEDRONIC ACID TARO PHARMACEUTICALS INC Discontinued 5MG New Report 2025-01-21 248172
CABLIVI SANOFI-AVENTIS CANADA INC Discontinued 11MG New Report 2025-01-17 248053
CABLIVI SANOFI-AVENTIS CANADA INC Discontinued 11MG New Report 2025-01-16 247940
ELAVIL AA PHARMA INC To be discontinued 75MG New Report 2025-01-16 247842
ELAVIL AA PHARMA INC To be discontinued 50MG New Report 2025-01-16 247839